Dexamethason for the treatment of exacerbations in multiple sclerosis

Dexamethason for the treatment of exacerbations in multiple sclerosis

Completed (inferred)Relapsing and progressiveISRCTN40435212

What was tested

Treatment tested

  • Dexamethason

What it measured

Main measures

  • The number of patients who describe an improvement in their clinical status of at least five points on a ten point Likert scale (zero = unchanged, nine = complete recovery to the pre-exacerbation level) on day six.

Other measures (1)

  • 1. The number of patients needing additional intravenous methylprednisolon-treatment. 2. The number of patients who describe an improvement of at least five points on a ten-point-Likert scale on day 14 and 28. 3. The number of patients with at least one point improvement on the Expanded Disability Status Scale (EDSS) on day six, 14, 28 compared to the EDSS-score at randomisation.

    Disability progression

Loading reviews and guidelines…

History

  1. In scope changed from true to false

  1. Started

    Sept 2006

  2. Finished

    Sept 2007

Assembled by software from public sources.